Molecular Radiobiology of Protons Compared to Other Low Linear Energy Transfer (LET) Radiation

Topic Information

Dear Colleagues,

Advanced radiation delivery systems offer significant benefits in cancer treatment; however, there is potential for harm to normal tissue. There is strong and growing interest in proton radiation due to its use in cancer treatment, its prominent role in space radiation exposure, and its ability to inflict a substantial portion of the biological damage caused by neutrons. Protons are a type of low linear energy transfer (LET) radiation, such as X-rays or electrons, that covers a wide energy range. However, at low energies near the Bragg peak (<5 MeV), they become high LET. High-energy protons (>50 MeV) generate copious amounts of secondary radiation, including neutrons and high-LET charged particles. In addition, there is growing interest in advanced radiation modalities, including ultra-high dose rate (FLASH) proton irradiation. There is significant overlap in the approaches used to elucidate molecular mechanisms in the areas of radiation cancer treatment as well as the risks in the diagnostic use of radiation and to radiation workers on Earth and in space. Research in these areas has seen substantial progress in recent years, and this Special Issue aims to provide a comprehensive overview of the biomolecular changes caused by proton radiation and comparisons with X-rays and other low LET radiation. We encourage the submission of original full research papers as well as review articles that present novel mechanistic insights, new techniques, experimental models, predictive theoretical models, and datasets.

Topics include, but are not limited to, the following:

• Comparisons of protons to X-rays and electrons of varying energies in cancer therapy and normal tissue damage;
• Initial and persistent DNA and reactive oxygen species (ROS) damage, damage processing, and aberrant signaling in cells and tissue;
• Creation of omics databases of proton effects;
• Use of artificial intelligence and machine learning in describing and comparing protons with other low LET radiation molecular changes related to health risks;
• Immune-proton therapy;
• Molecular changes causative of non-cancer effects such as cognitive impairments, cataracts, and circulatory disease risks following proton radiation exposure;
• FLASH proton irradiation;
• Molecular changes leading to health risks from solar particle events and cosmic rays.

Prof. Dr. Francis Cucinotta
Prof. Dr. Jacob Raber
Topic Editors

Keywords

Participating Journals

Journal Name	Impact Factor	CiteScore	Launched Year	First Decision (median)	APC
Biophysica biophysica	-	1.6	2021	16.1 Days	CHF 1000	Submit
Current Issues in Molecular Biology cimb	2.8	2.9	1999	15.8 Days	CHF 2200	Submit
Diagnostics diagnostics	3.0	4.7	2011	20.3 Days	CHF 2600	Submit
International Journal of Molecular Sciences ijms	4.9	8.1	2000	16.8 Days	CHF 2900	Submit
International Journal of Translational Medicine ijtm	-	-	2021	24.2 Days	CHF 1000	Submit

Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

1. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
2. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
3. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
4. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
5. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers